Pages that link to "Q32139406"
The following pages link to Bisphosphonates for the relief of pain secondary to bone metastases. (Q32139406):
Displaying 50 items.
- Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis (Q21132670) (← links)
- Radioisotopes for metastatic bone pain (Q24235589) (← links)
- Bisphosphonates in multiple myeloma (Q24236776) (← links)
- Calcitonin for metastatic bone pain (Q24245128) (← links)
- Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis (Q24608900) (← links)
- Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases (Q26997330) (← links)
- Chemotherapy- and irradiation-induced bone loss in adults with solid tumors (Q28084019) (← links)
- Synthesis and biological evaluation of a new polymeric conjugate and nanocarrier with osteotropic properties (Q28386509) (← links)
- How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews (Q30483437) (← links)
- Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan (Q33291614) (← links)
- WITHDRAWN: Radioisotopes for metastatic bone pain (Q33440341) (← links)
- An observational study of musculoskeletal pain among patients receiving bisphosphonate therapy (Q33765055) (← links)
- Recent developments in bisphosphonates for patients with metastatic breast cancer (Q33935632) (← links)
- The good pain management (GPM) ward program in China and its impact on Chinese cancer patients: the SYSUCC experience (Q33947848) (← links)
- Bone Health in Nonmetastatic Prostate Cancer: What’s the Big Deal? (Q34111621) (← links)
- The application of genomic and molecular data in the treatment of chronic cancer pain (Q34207230) (← links)
- Zoledronate for metastatic bone disease and pain: a meta-analysis of randomized clinical trials. (Q34320376) (← links)
- Modular 'click-in-emulsion' bone-targeted nanogels. (Q34320432) (← links)
- Improving management of patients with advanced cancer (Q34413634) (← links)
- Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer (Q35208717) (← links)
- Assessment of the effects of zoledronic Acid therapy on bone metabolic indicators in hormone-resistant prostate cancer patients with bone metastatasis (Q35377151) (← links)
- Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice (Q35667196) (← links)
- Analgesia for patients with advanced disease: 2 (Q35745100) (← links)
- A randomized controlled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis (Q35748849) (← links)
- Prevention and Treatment of Bone Metastases in Breast Cancer (Q35750652) (← links)
- The pathophysiology of cancer-induced bone pain: current understanding (Q35805721) (← links)
- A primer of bone metastases management in breast cancer patients (Q36410656) (← links)
- The role of bisphosphonates in the management of prostate cancer (Q36450794) (← links)
- 'Who', 'when' and 'how' in re-irradiation of recurrent painful bone metastases (Q36491439) (← links)
- Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines? (Q36628819) (← links)
- Risks and benefits of bisphosphonates (Q36696538) (← links)
- Pathways to breast cancer recurrence. (Q36702139) (← links)
- Canadian recommendations for the management of breakthrough cancer pain (Q36807866) (← links)
- Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines (Q36919568) (← links)
- Metastatic malignant melanoma of the conjunctiva: a case report (Q37097443) (← links)
- Management of breakthrough pain in patients with cancer. (Q37154731) (← links)
- Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments. (Q37187646) (← links)
- Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group (Q37228487) (← links)
- Metastatic bone pain: treatment options with an emphasis on bisphosphonates (Q37235971) (← links)
- Bone targeted treatments in cancer - The story so far (Q37337487) (← links)
- Optimal management of bone metastases in breast cancer patients (Q37355487) (← links)
- Recent advances in cancer pain management (Q37552355) (← links)
- Cancer pain: part 1: Pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners (Q37764968) (← links)
- The use of bisphosphonates in cancer treatment (Q37800183) (← links)
- Androgen deprivation and bone (Q37821350) (← links)
- A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain (Q38166276) (← links)
- Analgesic prescribing in palliative care (Q38285562) (← links)
- Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort (Q38791807) (← links)
- Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study (Q39347649) (← links)
- Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome (Q39381651) (← links)